| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $45,459,164 ) (Continued on the next page) |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | UH3CA271377 | APPLICATION OF A MULTIPLEXED IMMUNOASSAY FOR THE DETECTION OF BLADDER CANCER | 000 | 1 | NIH | 6/20/2022 | $458,020 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL159953 | Syndecan-1 suppression of lung inflammation | 000 | 1 | NIH | 4/25/2022 | $600,248 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL159160 | Basal cells in airway and alveolar remodeling | 000 | 1 | NIH | 4/28/2022 | $604,959 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL160908 | The role of GATA3-positive macrophages in cardiovascular pathologies | 000 | 1 | NIH | 6/13/2022 | $417,500 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01DK131071 | FGFR Signaling in Liver Injury and Fibrosis | 000 | 1 | NIH | 6/7/2022 | $438,059 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL164983 | Assessment of Mast Cell Degranulation in Infarcted Myocardium Using Quantitative Multiparametric MRI | 000 | 1 | NIH | 6/13/2022 | $834,798 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01EB032801 | Fully Quantitative Low-Dose, Motion-Resolved Dynamic Contrast-Enhanced MRI in Pancreatic Adenocarcinoma | 000 | 1 | NIH | 6/15/2022 | $586,150 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01AI165797 | A novel mechanism for NLRP3 inflammasome activation in human macrophages | 000 | 1 | NIH | 6/15/2022 | $765,715 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | K01AG076865 | Developing and Testing a Population Health Approach to Deprescribing and Optimizing Medications in Older Adults | 000 | 1 | NIH | 5/18/2022 | $124,854 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA258204 | Targeting inhibitor-resistant breast tumors with HER3-homing nano-capsids | 000 | 1 | NIH | 5/9/2022 | $372,817 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R00NR018679 | Is Preeclampsia and Spontaneous Preterm Delivery Associated with Vascular and Cardiac Function? | 000 | 3 | NIH | 5/31/2022 | $249,000 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL165169 | Autoantibody-induced type 1 interferons and RBC alloimmunization in sickle cell disease | 000 | 1 | NIH | 6/10/2022 | $417,500 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R21CA259911 | Targeted nano-boron based boron neutron capture therapy for glioma treatment | 000 | 1 | NIH | 4/1/2022 | $209,377 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA270324 | Nucleocapsid bioparticles eliciting multi-pronged attack on tumor metastases | 000 | 1 | NIH | 4/15/2022 | $382,013 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R35HL161195 | Patient-specific Outcome Prediction from Cardiovascular Multimodality Imaging by Artificial Intelligence | 000 | 1 | NIH | 4/4/2022 | $1,027,005 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01AI164519 | ACE and myeloid cell metabolism | 000 | 1 | NIH | 2/11/2022 | $555,387 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01DK130851 | Evaluating environmental control (AVOID) and inhibitory control (RESIST) strategies to improve weight management outcomes | 000 | 1 | NIH | 2/10/2022 | $748,583 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01EY029677 | Role of type 2 Innate Lymphoid Cells (ILC2s) in optic neuritis | 000 | 4 | NIH | 2/10/2022 | $427,982 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL160860 | A hypercholesterolemia-induced immunometabolite in atherosclerosis | 000 | 1 | NIH | 11/30/2021 | $694,138 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL160860 | A hypercholesterolemia-induced immunometabolite in atherosclerosis | 001 | 1 | NIH | 1/28/2022 | $0 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R21CA256421 | Neoadjuvant anti-PD-1 immunotherapy and Stereotactic Radiation in Patients with Recurrent Glioblastoma | 000 | 1 | NIH | 12/8/2021 | $195,181 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | DP1DK130687 | Is Obesity an Infectious Disease?: Gut bacterial and fungal translocation as an underappreciated driver of visceral adipose expansion. | 000 | 2 | NIH | 6/3/2022 | $819,352 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R03AG073993 | Days spent at home: a patient-centered outcome measure for persons with Alzheimer's disease and related dementias | 000 | 2 | NIH | 4/28/2022 | $167,000 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01AG075998 | The role of Chlamydia pneumoniae infection in Alzheimer's Disease | 000 | 2 | NIH | 5/31/2022 | $662,840 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R00HL141702 | Metabolic Rewiring of the Heart Through Reductive Carboxylation | 000 | 5 | NIH | 5/3/2022 | $248,999 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01NS121544 | Unified Shim-RF Coil Technology for Improved Whole-Brain Spectroscopic MRI for Neurological Disorders | 000 | 2 | NIH | 4/5/2022 | $465,256 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | UH3NS105703 | Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic | 000 | 5 | NIH | 4/1/2022 | $549,019 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | UH3NS105703 | Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic | 000 | 5 | NIH | 4/1/2022 | $625,000 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | K99HL157421 | Deep Learning Assessment of the Right Ventricle: Function, Etiology, and Prognosis | 000 | 2 | NIH | 3/17/2022 | $158,613 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL151828 | Vaccine Induced Immune-Inflammatory Response and Cardiovascular Risk | 000 | 2 | NIH | 4/12/2022 | $656,237 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | K08CA259456 | Targeting the Stroma for Pancreatic Cancer Treatment | 000 | 3 | NIH | 4/7/2022 | $244,172 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA258265 | Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities | 001 | 2 | NIH | 5/25/2022 | $48,295 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA258265 | Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities | 000 | 2 | NIH | 2/23/2022 | $434,626 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA258222 | Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators | 000 | 2 | NIH | 6/13/2022 | $867,802 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01NR019947 | Transcending COVID-19 barriers to pain care in rural America: Pragmatic comparative effectiveness trial of evidence-based, on-demand, digital behavioral treatments for chronic pain | 000 | 2 | NIH | 4/18/2022 | $966,674 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01AI162765 | DAP12 and the host response to cryptococcosis | 000 | 2 | NIH | 6/14/2022 | $571,755 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA252211 | Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes | 000 | 2 | NIH | 5/3/2022 | $680,220 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01DK125495 | Targeting the Mycobiome in Genetically Defined Patients with Crohns Disease | 000 | 2 | NIH | 3/29/2022 | $640,531 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R21HL156132 | Behavioral Economics to improve Antihypertensive Therapy Adherence (BETA) | 000 | 2 | NIH | 5/19/2022 | $223,719 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | K08CA245483 | Decoupling Bidirectional EphB/ephrinB2 in Multiple Myeloma | 000 | 3 | NIH | 4/19/2022 | $256,859 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01CA244569 | Characterizing non-coding somatic and germline variant interactions in ovarian cancer | 000 | 3 | NIH | 5/26/2022 | $663,739 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01NR018762 | Novel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics and Behaviors | 000 | 3 | NIH | 4/1/2022 | $664,970 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | U01TR002756 | Collaborative care teams for hospitalized patients with opioid use disorders: Translating evidence into practice | 000 | 3 | NIH | 6/10/2022 | $250,000 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | U01TR002756 | Collaborative care teams for hospitalized patients with opioid use disorders: Translating evidence into practice | 000 | 3 | NIH | 6/10/2022 | $984,032 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL149972 | RNA-Mediated Inter-Organelle Communication in Atherosclerosis | 001 | 3 | NIH | 5/27/2022 | $498,851 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | U01AI156922 | Mitigation of Radiation Injury via Vascular Regeneration and Remodeling | 000 | 3 | NIH | 5/17/2022 | $501,000 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL148787 | Integrated prediction of cardiovascular events by automated coronary plaque and pericoronary adipose tissue quantification from CT Angiography | 001 | 3 | NIH | 5/31/2022 | $69,522 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL148787 | Integrated prediction of cardiovascular events by automated coronary plaque and pericoronary adipose tissue quantification from CT Angiography | 000 | 3 | NIH | 3/22/2022 | $625,689 |
| | 2022 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | LOS ANGELES | CA | 90048-1804 | LOS ANGELES | USA | R01HL152156 | A lipid-induced RNA-binding protein in atherosclerosis | 002 | 3 | NIH | 6/13/2022 | $46,691 |
|
